Sort by
Refine Your Search
-
Listed
-
Employer
- University of Basel
- ETH Zürich
- Empa
- Universität Bern
- ZHAW - Zurich University of Applied Sciences
- Academic Europe
- EPFL
- ETH Zurich
- Ecole Polytechnique Federale de Lausanne
- Ecole Polytechnique Federale de Lausanne - EPFL
- Paul Scherrer Institut Villigen
- Swiss Federal Institute for Forest, Snow and Landscape Research WSL
- University of Applied Sciences Northwestern Switzerland
- University of Bern
- University of Zurich
- École Polytechnique Fédérale de Lausanne (EPFL)
- 6 more »
- « less
-
Field
-
-house gelatin- and peptide-based formulations, which will be further refined through integration with advanced scaffold materials developed by partners (such as plasma-activated materials). These bioinks
-
platform for thrombolysis in cases of drug embolism. To this end, a model of the pulmonary circulation shall be developed. It will include models for the transport of thromboemboli and drugs. This model will
-
robustness and efficiency of adaptation, specifically to (i) implement always-on online plasticity circuits that stop changing the weights when learning is not necessary anymore and (ii) implement selective
-
and validate developed methods on embedded platforms and sensor prototypes. Collaborate with experts in embedded systems, digital IC design, and applications to realize end-to-end human–computer
-
how perishable biological products, such as vaccines, react inside cold chain unit operations and to pinpoint why some products decay faster. For that purpose, we develop digital twins of the cargo
-
are looking for you! Do you want to be trained to develop multi-level thrombosis risk prediction models by integrating insights from cell-, thrombus-, and organ-level perspectives? While being part of a
-
standards. One crucial element to combat the endemic of healthcare-associated infections is being able to trace and track the transmission pathways of pathogens to develop effective interventions. There is a
-
-bleaching of the fluorescent dyes involved, which ends the experiment prematurely, rendering many biological questions inaccessible. To bypass this limitation, our group has developed DyeCycling/FRET, where
-
the efficiency in the end use. In addition, the electric energy grid is rebuilt and extended to incorporate these changes and aims to use only environmentally friendly components. Job description SF6 is today
-
Your position A fully funded PhD position is available in the Computational Pharmacy group at the University of Basel. The successful candidate will contribute to ongoing research on the development